Tumor Ablation Devices Market to Set Phenomenal Growth from 2017 to 2025 Profiling Boston Scientific Corporation, Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson, Smith & Nephew Plc., Angiodynamics, HealthTronics, Inc, Abbott Laboratories

With the robust development of imaging devices and modalities during past two decades, image-guided techniques like tumor ablation have become a powerful tool for the definitive treatment of certain benign and malignant tumors of the lungs, liver, kidneys, bone, and soft tissues and for pain palliation. Tumor ablation is one of the minimally invasive procedures used to destroy cancer cells in the chest, lung and liver and other areas of the patients’ body. The change in lifestyle and unhealthy eating habits, along with increasing consumption of tobacco and alcohol is the leading cause for growth in a number of cancer cases. As per stats released by the National Cancer Institute (NCI), around 1,685,210 new cases of cancer were diagnosed in the U.S. in 2016.

The global tumor ablation devices market is valued at US$ 464.18 million in 2017 and is expected to witness a CAGR of 10.2% over the forecast period (2017 – 2025).

Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1270

Market Dynamics:

Rising prevalence of tumor cases is the major factor that contributes to the growth of the tumor ablation devices market. According to the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with a primary brain and central nervous system malignant tumors. Various key players are involved in the sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablation, etc. Moreover, key players are also indulged in offering various lucrative features to the potential buyers of the ablation devices such as hospitals and clinics that would, in turn, help them to grow their sales and establish a global market presence. For instance, Medtronic launched OsteoCool RF Ablation System to treat spine metastases, in January 2016. The system destroys cancer cells by using high-frequency energy and also provides procedural flexibility and tailored treatment for spine metastases. However, the cost of tumor treatment is relatively expensive which may restrain the growth of the market.

Competitive Analysis:

The key players operating in the global market of tumor ablation devices include Boston Scientific Corporation, Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson, Smith & Nephew Plc., Angiodynamics, HealthTronics, Inc, SonaCare Medical, LLC., Galil Medical Inc., EDAP TMS S.A., Abbott Laboratories, NuVasive, Inc, Alpinion Medical Systems Co., Ltd.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1270

Detailed Segmentation:

• Global Tumor Ablation Devices Market, By Technology:
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- High-Intensity Focused Ultrasound
- Laser Interstitial Thermal Ablation
- Others

• Global Tumor Ablation Devices Market, By Application:
- Breast Cancer
- Liver Cancer
- Prostate Cancer
- Lung Cancer
- Kidney Cancer
- Others

• Global Tumor Ablation Devices Market, By End User:
- Hospitals
- Ambulatory Surgical Centers

• Global Tumor Ablation Devices Market, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa

Else place an Inquire before Purchase “Global Tumor Ablation Devices Market Size, Status and Forecast 2025": https://www.coherentmarketinsights.com/insight/talk-to-analyst/1270

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.